Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Blood|October 15, 2011
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemiaFortunato Morabito, Rosaria De Filippi, Luca Laurenti, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Hematological Oncology|March 31, 2018
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemiaGiovanni D'Arena, Candida Vitale, Giovanni Rossi, et al.
British Journal of Haematology|May 15, 2009
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemiaFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
American Journal of Hematology|July 29, 2016
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patientsStefano Molica, Tait D Shanafelt, Diana Giannarelli, et al.
American Journal of Hematology|April 9, 2014
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Laura Mosca, et al.
Hematological Oncology|September 29, 2023
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE studyPaolo Sportoletti, Luca Laurenti, Annalisa Chiarenza, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2014
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugsMassimo Martino, Maurizio Postorino, Giuseppe Alberto Gallo, et al.
Leukemia Research|June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatmentFortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
Plos One|June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR TechniquesAnna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.
Pageof 16